Gutron

Gutron is an oral prescription medication that contains the active ingredient midodrine hydrochloride. It is formulated as a tablet (strength not specified) and is marketed in the European Union. Midodrine belongs to the alpha‑1 adrenergic agonist class and works as a prodrug that is converted to desglymidodrine, producing peripheral vasoconstriction to raise blood pressure. Gutron is used under medical supervision for patients with orthostatic hypotension.

Gutron is indicated for the management of orthostatic hypotension, a condition characterized by a significant drop in blood pressure upon standing.

- Treatment of symptomatic orthostatic hypotension in adults. - Adjunct therapy for patients who experience dizziness or fainting due to low standing blood pressure. - Support for individuals with autonomic failure where blood pressure regulation is impaired. - Use in clinical settings where non‑pharmacologic measures such as compression stockings are insufficient.

The safety profile of Gutron includes a range of adverse effects that vary in frequency and severity.

Common: - Elevated supine blood pressure. - Piloerection (goosebumps). - Itching or rash. - Urinary urgency or retention.

Serious: - Severe hypertension, especially when lying down. - Cardiac arrhythmias. - Ischemic events such as angina.

Because Gutron influences vascular tone and blood pressure, several precautions should be observed before and during therapy.

- Avoid use in patients with severe cardiac disease or uncontrolled hypertension. - Monitor supine blood pressure regularly. - Caution in individuals with renal or hepatic impairment. - Do not administer to patients with pheochromocytoma. - Consider dose adjustment in elderly patients. - Avoid abrupt discontinuation to reduce risk of rebound hypotension.

Gutron may interact with other medications that affect blood pressure, heart rate, or vascular tone, requiring careful management.

Avoid: - Monoamine oxidase inhibitors (MAOIs). - Direct-acting vasoconstrictors such as phenylephrine. - Other alpha‑adrenergic agonists combined with midodrine.

Use with caution: - Diuretics, which may enhance hypotensive effects. - Antihypertensive agents including ACE inhibitors and beta‑blockers. - Tricyclic antidepressants, due to potential additive pressor effect. - Surgical anesthesia, because of increased risk of intra‑operative hypertension.